Group 1 - The core product of the company, "Kuaikeqing" oseltamivir phosphate capsules, was approved last October and is now available in both offline pharmacies and online platforms, facilitating easy access for patients [2] - The main ingredient of the product is oseltamivir phosphate, which is used for the treatment and prevention of influenza A and B in both adults and children [2] - The company has established an efficient production and sales linkage mechanism, allowing for real-time adjustments in production capacity based on market sales conditions to ensure a safe and stable supply of the medication [2]

Core Viewpoint - The company has confirmed that its subsidiary in Hainan Free Trade Zone is producing Oseltamivir, a medication used for treating and preventing influenza, and has established a robust production and sales mechanism to ensure stable supply [2]. Group 1: Product Information - The company's wholly-owned subsidiary, Hainan Asia Pharmaceutical Co., Ltd., has received approval for its Oseltamivir capsules, branded as "Kuaikqing," in October of the previous year [2]. - The product is available for purchase through both offline pharmacies and online platforms, facilitating easy access for patients [2]. Group 2: Production Capacity - The company has implemented an efficient production and sales linkage mechanism that allows for real-time adjustments in production capacity based on market demand [2]. - This system ensures a safe and stable supply of the medication to meet the needs of the market [2].